Paul John Courtney Woodward

All filings by Paul John Courtney Woodward on record concern Advanced Proteome Therapeutics Corporation. The record holds 40 filings, for trades running from 23 September 2016 to 23 December 2022.

On the open market, the record shows 7 purchases worth €3,917 and 20 sales worth €53k. On balance, insiders were net sellers of €49k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 option exercises. 2022 to date brings 6 purchases and no sales.

Half of the purchases are above €388 and half below. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 23 December 2022, reports a transaction of €50k in Advanced Proteome Therapeutics Corporation. The clock since the last published purchase (22 December 2022) now reads 1,402 days. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.